Vanda Pharmaceuticals





Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -125.8M 20.45M 2025-06
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alnylam Pharmaceuticals USD 381.78M 362.95M 2025-09
Anika Therapeutics USD -2.69M 4.73M 2025-03
Arrowhead Research USD 64.2M 223.53M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Esperion Therapeutics USD -27.51M 9.5M 2023-09
Halozyme Therapeutics USD 248.25M 22.74M 2025-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -297.13M 71.11M 2025-06
J&J USD 9.52B 389M 2025-09
Ligand Pharmaceuticals USD 20.9M 61.44M 2025-06
Merck USD 8.39B 1.97B 2025-09
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Moderna USD -208M 552M 2025-09
Novartis USD 5.84B 235M 2025-09
Pfizer USD 6.08B 351M 2025-09
PTC Therapeutics USD -33.11M 1B 2025-06
Puma Biotechnology USD 729K 11.36M 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
Takeda JPY 448.13B 173.98B 2025-12
Teva Pharmaceutical Industries USD 1.64B 243M 2025-12
Ultragenyx Pharmaceutical USD -91.34M 35.09M 2025-06
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12
Veracyte USD 39.73M 3.96M 2025-09


Vanda Pharmaceuticals - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.